Alzheimer's Disease Genetics Consortium — GERARD DAVID SCHELLENBERG (UNIVERSITY OF PENNSYLVANIA)
The goal of the Alzheimer's Disease Genetics Consortium (ADGC) is to completely resolve the genetics of Alzheimer's disease (AD). We will identify both common and rare variants to cause AD, alter AD r
| Project title | Alzheimer's Disease Genetics Consortium |
|---|---|
| Project number | 5U01AG032984-15 |
| PI name | GERARD DAVID SCHELLENBERG |
| Institution | UNIVERSITY OF PENNSYLVANIA |
| Funding mechanism | U01 |
| Agency | NIA |
| Award amount | $3.96M |
| Fiscal year | 2024 |
| Project start | 2009-04-01T00:00:00 |
| Project end | 2027-03-31T00:00:00 |
| Abstract | The goal of the Alzheimer's Disease Genetics Consortium (ADGC) is to completely resolve the genetics of Alzheimer's disease (AD). We will identify both common and rare variants to cause AD, alter AD r |
| Key terms | <3C-based approach><3C-based assay><3C-based method><3C-based strategy><3C-based technique><3C-based |
$799/mo
Try GrantRadar →